Wink….and LASH OUT at Lung Cancer!® to Help Support Lung Cancer Awareness in Women


On November 1, 2017, the Lung Cancer Research Foundation launched the Wink….and LASH OUT at Lung Cancer!® campaign to help support lung cancer awareness in women. To participate, post a photo on social media winking and lashing out at lung cancer. Use the hashtag #WinkandLashOut. 

The Facts: Women and Lung Cancer

  • Lung cancer is the number one cancer killer in women.
  • Lung cancer kills more women than breast, ovarian and cervical cancers combined.
  • Worldwide, over 400,000 women die of lung cancer each year.
  • While lung cancer diagnoses have been steadily decreasing for men, they appear to be leveling off for women in recent years.
  • Lung adenocarcinoma is the most common type of lung cancer found in women and men in the US.
  • Lung cancer has overtaken breast cancer as the leading cancer killer of women in developed countries, reflecting changing smoking patterns.
  • While smoking represents the number one risk factor for developing lung cancer, up to 20 percent of women who are diagnosed with lung cancer may have never touched a cigarette.
  • Non-smokers who develop lung cancer are more likely to be women than men.
  • It is estimated that nearly 60,000 women die of lung cancer each year in the US.
  • In 2017, an estimated 78,053 women will be diagnosed with lung cancer in the US alone.
  • Lung cancer in women who have never smoked tends to occur in younger women and Asian women.

About the Wink….and LASH OUT at Lung Cancer®! campaign

  • Read the campaign press release
  • Share your photos! Using the hashtag #WinkandLashOut, post a photo winking and lashing out at lung cancer to help raise awareness about women and lung cancer. Your photo may be featured on the Lung Cancer Research Foundation's website, social media channels and in promotional materials.


The Lung Cancer Research Foundation’s women and lung cancer campaign has been supported in part by:

Anonymous; Astellas; Dianne Barker; Bristol-Myers Squibb; Leonor Coello; M. Carol Gardner; Dina Garland; Genentech; Missy Gothard; Christina Guthman; Katasha Harley; Lauren Hulkiwer; Jeweled Kisses by Jade; Kimberly Kravis; Amalia Dayan Lindemann; Adam Lindemann; Delia Naughton; Jennifer Mormile; Paragon Management Associates, Inc.; Nancy Sanford; Patricia Smith  


Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD. 

Kovalchik SA, De Matteis S, Landi MT, et al. A regression model for risk difference estimation in population-based case–control studies clarifies gender differences in lung cancer risk of smokers and never smokers. BMC Med Res Methodol 2013;13:143.

PDQ® Adult Treatment Editorial Board. PDQ Non-Small Cell Lung Cancer Treatment. Bethesda, MD: National Cancer Institute. Sewart, Bernard W, and Christopher P Wild. World Cancer Report 2014. Lyon: International Agency for Research on Cancer/World Health Organization, 2014. 

Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers--a different disease. Nat Rev Cancer. 2007 Oct;7(10):778-90.  Tam IY, Chung LP, Suen WS, et al. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cancer Res 2006;12:1647–1653.  Zang EA, Wynder EL. Differences in lung cancer risk between men and women: Examination of the evidence. J Natl Cancer Inst 1996;88:183–192.

Photo Gallery 2018